MedTech Navigator Reverse Pitch Series: Johnson & Johnson
Event Description
Join MedTech Navigator for an exclusive reverse pitch session featuring Johnson & Johnson, one of the world's leading healthcare companies.
Unlike a traditional pitch event, this session puts the spotlight on Johnson & Johnson, providing Australian MedTech companies with direct insight into the company's strategic priorities, procurement needs, supply chain challenges, and partnership opportunities. Participants will hear firsthand what Johnson & Johnson looks for in potential collaborators and gain practical guidance on engaging with a global MedTech leader.
The session will conclude with an interactive Q&A and short company introductions, providing attendees with an opportunity to showcase their capabilities and identify potential areas of alignment.
Key Takeaways
Attendees will:
- Gain insight into Johnson & Johnson's current strategic, procurement and supply chain priorities.
- Understand the challenges and opportunities where external partners can add value.
- Learn what global MedTech companies look for in prospective collaborators, suppliers and innovation partners.
- Better understand expectations around capability, commercial readiness and regulatory requirements.
- Receive practical guidance on how to effectively approach and engage with multinational MedTech organisations.
- Build awareness of potential pathways for international partnerships, market access and supply chain integration.
Target Audience
This session is designed for Australian MedTech companies, including:
- Medical device, diagnostic and digital health (including SaMD) innovators.
- Early-stage startups, researchers and spinouts progressing towards commercialisation.
- Growth-stage and established SMEs seeking partnership opportunities with multinational companies.
- Organisations interested in international market expansion, procurement pathways, strategic partnerships and supply chain integration.
- Participants in the MedTech Navigator program and the broader Australian MedTech ecosystem.
Recommended for: Founders, CEOs, business development leaders, commercialisation managers, innovation leads and industry engagement professionals.
Find out more about MedTech Navigator here: https://medtechcompass.org.au/navigator/
MedTech Navigator is delivered in collaboration with the Australian Trade and Investment Commission, Austrade.
The Trade Diversification Network has been set up to deliver the Accessing New Markets Initiative, bringing together national peak industry bodies representing Australian exporters.
By combining MTAA’s industry connections with Austrade’s international trade expertise and networks, MedTech Navigator helps Australian companies better understand and prepare for opportunities in global markets.
Please note: This webinar will be recorded and may be shared in the future at the discretion of the MTAA and that by registering for this event you agree to MTAA's Terms and Conditions and MTAA's Privacy Policy.
Contact Information
Additional Information
Your Speakers
Peter Hawkes is Cluster Lead, MedTech Australia & New Zealand and Vice President, Surgery at Johnson & Johnson MedTech. He leads the company’s Surgery business across Australia and New Zealand, partnering with healthcare providers, clinicians, and industry stakeholders to advance innovative surgical technologies, digital solutions, and patient care. Over more than 16 years with Johnson & Johnson, Peter has held senior commercial, strategic, and business development leadership roles across Australia, Asia, and North America. He is recognised for driving business growth, shaping strategy, and building high-performing teams and cultures focused on accountability, innovation, and execution.
Peter previously spent five years in Asia leading strategic partnerships with emerging healthcare technology companies, digital health innovators, and institutions aligned to Johnson & Johnson’s MedTech strategy. His work spanned digital health, artificial intelligence, and healthcare innovation across the Asia-Pacific region. He holds an MBA from Macquarie Graduate School of Management, a Graduate Diploma in Applied Finance and Investment from FINSIA, and a Bachelor of Economics from the University of Sydney.
As Innovation & Growth Lead at the Medical Technology Association of Australia (MTAA), I work at the intersection of industry, capital and policy to strengthen and scale Australia’s Medtech ecosystem. My focus is on unlocking growth pathways for medical technology companies, from early-stage innovation through to global expansion, and ensuring the right investment, regulatory and commercial settings exist for success. Medtech is not just my sector - it’s my expertise. I bring deep knowledge across innovation pipelines, capital strategy, reimbursement, regulation and commercialisation. I’m passionate about translating complex industry issues into clear, strategic conversations that drive outcomes for patients, companies and the broader healthcare system.
